Nordic Completes $846m Takeover Of Advanz
Firm Plans ‘Considerable Investment In Our Organic And Inorganic Pipeline’
Nordic Capital has completed its takeover of Advanz Pharma, three years after the company’s transformation from its former identity of Concordia. The company is planning “considerable investment” following the deal.